These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10472412)
1. Schizophrenia as a neuronal illness. Freedman R Biol Psychiatry; 1999 Sep; 46(5):587-8. PubMed ID: 10472412 [No Abstract] [Full Text] [Related]
2. Neurodevelopment, GABA system dysfunction, and schizophrenia. Schmidt MJ; Mirnics K Neuropsychopharmacology; 2015 Jan; 40(1):190-206. PubMed ID: 24759129 [TBL] [Abstract][Full Text] [Related]
3. [Possible relevance of alterations at the cellular, neuronal connectivity and brain structure levels to the pathophysiology of schizophrenia]. Berger E; Shiloh R; Weizman A; Munitz H Harefuah; 2001 Jul; 140(7):648-52. PubMed ID: 11481973 [No Abstract] [Full Text] [Related]
4. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism. Tamminga CA; Burrows GH; Chase TN; Alphs LD; Thaker GK Ann N Y Acad Sci; 1988; 537():443-50. PubMed ID: 2904785 [No Abstract] [Full Text] [Related]
5. The neurobiology of cognition in schizophrenia. Tamminga CA J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183 [TBL] [Abstract][Full Text] [Related]
6. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else? Benes FM Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640 [No Abstract] [Full Text] [Related]
7. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Benes FM Schizophr Bull; 1998; 24(2):219-30. PubMed ID: 9613622 [TBL] [Abstract][Full Text] [Related]
9. The neurobiology of cognition in schizophrenia. Tamminga CA J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078 [TBL] [Abstract][Full Text] [Related]
10. [Neuroleptics and nicotine]. Erdmann R Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751 [TBL] [Abstract][Full Text] [Related]
11. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons. Rasmussen K Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172 [No Abstract] [Full Text] [Related]
12. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment]. Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745 [TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance. Lafargue T; Brasic J Med Hypotheses; 2000 Oct; 55(4):314-8. PubMed ID: 11000059 [TBL] [Abstract][Full Text] [Related]
14. Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Pillai A; Mahadik SP Schizophr Res; 2008 Mar; 100(1-3):325-33. PubMed ID: 18187310 [TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental model of schizophrenia. Feinberg I Biol Psychiatry; 1992 Jul; 32(2):212-3. PubMed ID: 1420639 [No Abstract] [Full Text] [Related]
16. The role of dopamine for the pathophysiology of schizophrenia. Meisenzahl EM; Schmitt GJ; Scheuerecker J; Möller HJ Int Rev Psychiatry; 2007 Aug; 19(4):337-45. PubMed ID: 17671867 [TBL] [Abstract][Full Text] [Related]
17. Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia. Waddington JL Schizophr Bull; 1993; 19(1):55-69. PubMed ID: 8451613 [TBL] [Abstract][Full Text] [Related]